NCT01451996View on ClinicalTrials.gov

The Efficacy of Claritin in Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
DRUG

Claritin

Subject will be given 10mg Claritin tablet.

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT01451996 - The Efficacy of Claritin in Healthy Subjects | Biotech Hunter | Biotech Hunter